| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.43▲ | 9.41▲ | 9.45▲ | 9.48▼ | 9.32▲ |
| MA10 | 9.41▲ | 9.39▲ | 9.47▲ | 9.31▲ | 8.85▲ |
| MA20 | 9.39▲ | 9.48▲ | 9.56▼ | 9.28▲ | 8.79▲ |
| MA50 | 9.40▲ | 9.53▼ | 9.43▲ | 8.88▲ | 8.59▲ |
| MA100 | 9.40▲ | 9.42▲ | 9.23▲ | 8.92▲ | 10.73▼ |
| MA200 | 9.53▼ | 9.24▲ | 9.14▲ | 9.04▲ | 12.41▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.005▲ | -0.029▼ | 0.027▲ | 0.078▲ |
| RSI | 58.760▲ | 50.871▲ | 50.119▲ | 56.856▲ | 54.044▲ |
| STOCH | 80.970▲ | 76.657 | 55.710 | 77.289 | 68.968 |
| WILL %R | -3.279▲ | -25.641 | -38.034 | -32.624 | -21.893▲ |
| CCI | 123.724▲ | 54.651 | -20.174 | 13.642 | 101.380▲ |
|
Tuesday, May 12, 2026 10:19 PM
Kura Oncology Inc (KURA) reports promising revenue from KOMZIFTI's debut, despite increased R&D and administrative costs impacting net loss.
|
|
Tuesday, May 12, 2026 07:08 PM
Is Kintara Therapeutics A Hidden Gem? Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is ...
|
|
Tuesday, May 12, 2026 01:28 PM
KOMZIFTI™ (ziftomenib) net product revenue in first full quarter of commercialization –– Robust new patient starts and early ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/26 | 8.97 | 9.54 | 8.76 | 9.48 | 2,427,528 |
| 12/05/26 | 9.52 | 9.94 | 9.38 | 9.68 | 1,840,027 |
| 11/05/26 | 9.51 | 9.94 | 9.51 | 9.51 | 1,181,802 |
| 08/05/26 | 9.35 | 9.51 | 9.33 | 9.42 | 889,209 |
| 07/05/26 | 9.56 | 9.61 | 9.05 | 9.32 | 947,755 |
| 06/05/26 | 9.35 | 9.61 | 9.27 | 9.56 | 1,066,236 |
| 05/05/26 | 9.34 | 9.415 | 9.035 | 9.29 | 816,874 |
| 04/05/26 | 8.92 | 9.42 | 8.85 | 9.25 | 1,307,368 |
| 01/05/26 | 8.77 | 8.935 | 8.67 | 8.77 | 1,217,943 |
| 30/04/26 | 8.85 | 8.95 | 8.78 | 8.83 | 774,011 |
|
|
||||
|
|
||||
|
|